When the Agriculture Improvement Act of 2018 (the 2018 Farm Bill) removed hemp from Schedule I of the federal Controlled Substances Act, many cannabinoids now making headlines were virtually unknown to farmers pinning their hopes on hemp. But the hemp market soon spawned a robust cannabinoid industry, with CBD as the star.
Since then, the industry of hemp-derived cannabinoids has assumed a life of its own, expanding to include minor cannabinoids having everything from well-researched benefits to novel, controversial and intoxicating unknowns. Staying abreast of trends and regulatory responses is akin to tracking moving targets. And producers who ventured into regulatory gray areas have become targets themselves.
